Preclinical assessment of synergistic efficacy of MELK and CDK inhibitors in adrenocortical cancer.
Laha D, Grant RRC, Mishra P, Boufraqech M, Shen M, Zhang YQ, Hall MD, Quezado M, De Melo MS, Del Rivero J, Zeiger M, Nilubol N.
Laha D, et al.
J Exp Clin Cancer Res. 2022 Sep 23;41(1):282. doi: 10.1186/s13046-022-02464-5.
J Exp Clin Cancer Res. 2022.
PMID: 36151566
Free PMC article.